Introduction
Endothelin (ET-1), a 21 amino acid peptide recently isolated from the culture medium of endothelial cells, is one of the most potent vasoconstrictors known. In isolated vascular strips of various experimental animals, ET-1 induces a vasoconstriction that is slow to develop and long-lasting. 2 ET-1 administered intravenously to healthy volunteers and pigs, 4 had a plasma half-life of about 1 min. Plasma ET-1 was cleared mainly by the kidney, splanchnic circulation and skeletal muscle. Despite its short plasma half-life, the systemic administration of ET-1 to various animal species induces a long-lasting pressure effect in vivo, an initial pressure response, either contraction or dilation depending on the species, followed by a secondary vasoconstriction of longer duration. -9 The transient hypotensive effect is thought to be mediated by potassium channels 1 and/or by ET-1 evoked release of endothelium derived relaxing factors.
1>5 ET-1 has been shown to contract non-vascular smooth muscle cells also, including guinea-pig tracheal and bronchial strips. 16 '7 In vivo potent bronchoconstrictor activity of ET-1 has been demonstrated in the guinea-pig and in the rat. 18 '19 Although the haemodynamic activity of ET 
